Researchers have shown how pre-existing immune cells in the blood may help individuals develop rapid and strong protection against hepatitis B infection following vaccination.

Scientists developed a multi-organoid system from human induced pluripotent stem cells (hiPSCs) to simulate human liver-islet axis in normal and T2DM.

Studying the sensory organs of a 100-million-year-old cockroach offers new insights into how the species may have lived.

Scientists at NTU Singapore have developed a new therapeutic approach to obesity and related metabolic disorders that in laboratory experiments demonstrated a significant reduction in body fat, body weight, and improvement in the blood markers that accompany these disorders. This method begins with an injection of a specially developed hydrogel using an insulin needle, into a fat deposit directly under the skin. A near infrared light is then shone on the site of the injection for five minutes a few times daily, over a few days, activating the hydrogel’s fat-burning ability.

A UCLA-led cost analysis of the controversial new Alzheimer’s disease drug aducanumab shows that ancillary care services, such as additional MRIs and neurologist visits to monitor the potential brain swelling and bleeding associated with the medication, account for nearly 20% of total Medicare costs related to the drug, or $6,564 per patient per year.

Decades of research on medical cannabis has focused on the compounds THC and CBD in clinical applications. But less is known about the therapeutic properties of cannabinol (CBN). Now, a new study by Salk scientists shows how CBN can protect nerve cells from oxidative damage, a major pathway to cell death. The findings suggest CBN has the potential for treating age-related neurodegenerative diseases, like Alzheimer’s.